Examiner: ALFANO, ALAN

Tech Center 1600 • Art Units: 1641

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

5.7%

§101 Eligibility

22.9%

§102 Novelty

25.7%

§103 Obviousness

34.3%

§112 Clarity

App #	Title	Status	Assignee
18357665	A CONJUGATE, COMPOSITION AND METHOD FOR NONCOVALENT ANTIBODY CATENATION THAT INCREASES ANTIGEN-BINDING AVIDITY OF AN ANTIBODY IN PROPORTION TO THE DENSITY OF A TARGET ANTIGEN	Non-Final OA	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
18333778	GENETICALLY ENGINEERED DIAGNOSTIC CELLS AND ANTIGEN TESTS	Non-Final OA	SRI International
18277594	ANTIBODIES	Non-Final OA	UCB BIOPHARMA SRL

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.